Delivery Order SPE2DB22D3401-SPE2DB24FT1XD
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BIKTARVY 50-200-25 MG TABLET in 30-count units. The $49,047.50 contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $18,447.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BIKTARVY 50-200-25 MG TABLET in support of military treatment programs and facilities. The contract has a potential value of $4,489.32 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, also holds an indefinite delivery contract (IDC) with DLA valued up to...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $9,293.28 worth of BIKTARVY 50-200-25 MG TABLET in a 30-count package. This delivery order contract has a completion date of February 13, 2024 and was awarded on February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this contract, which is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S pharmaceuticals. The contract has a completion date of January 30, 2024 and a potential value of $9,843.22. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of BIKTARVY 50-200-25 MG TABLET. The $32,373.58 contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 with a performance period...
- The Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication, with a ceiling value of $12,630.54 and a completion date of June 12, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a potential value of $25,608.41 and a completion date of March 5, 2024. The contract is for the delivery of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets per package. This delivery order is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, SPE2DB22D1106|SPE2DB24FEHN6, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. The $73,570.22 contract has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $15,672.81, is for the provision of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT1XDDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BIKTARVY 50-200-25 MG TABLET UU 30S. The potential value of this order is $8,987.46, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.
Generated 5/14/24, 12:20 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 2/13/24 |